Previous Close | 1.7800 |
Open | 1.7900 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 1000 |
Day's Range | 1.7150 - 1.7900 |
52 Week Range | 1.0300 - 3.1500 |
Volume | |
Avg. Volume | 53,045 |
Market Cap | 22.684M |
Beta (5Y Monthly) | 1.71 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.9260 |
Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for EKSO
Broadens Ekso Bionics’ product portfolio into home use Adds Vanderbilt University as a key commercial and research partner Acquisition consolidates leading lower extremity robotic companies Ekso President and COO Scott Davis promoted to Chief Executive Officer; Steven Sherman to remain Chairman, appointed Executive Chair SAN RAFAEL, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, t
Ekso Bionics Holdings ( NASDAQ:EKSO ) Third Quarter 2022 Results Key Financial Results Revenue: US$3.33m (up 9.2% from...
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?